ArticleCancers2022

Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study.

Sofia Genta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.